Sequenom Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sequenom Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011949
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby’s whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 13
Partnerships 14
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 14
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 15
Sequenom Enters Into Licensing Agreement With LifeCodexx 16
Sequenom enters into an Agreement with University of California 17
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 18
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 19
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 20
New England Biolabs Enters Into Licensing Agreement With Sequenom 21
Equity Offering 22
Sequenom Completes Public Offering Of Common Stock For US$62 Million 22
Debt Offering 24
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 24
Asset Transactions 26
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 26
Acquisition 27
LabCorp Acquires Sequenom 27
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 29
Sequenom Inc – Key Competitors 30
Sequenom Inc – Key Employees 31
Sequenom Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 34
Jan 07, 2016: Sequenom Announces Restructuring: Plans Sale Of North Carolina Operations And Initiatives To Improve Efficiencies 35
Financial Announcements 36
May 04, 2016: Sequenom Reports First Quarter 2016 Results 36
Mar 02, 2016: Sequenom Reports 2015 Financial Results 38
Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 40
Corporate Communications 41
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 41
Legal and Regulatory 42
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom’s Petition Requesting Review Of Decision On ’540 Patent 42
Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On ’540 Patent 43
Product News 44
02/25/2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 44
01/11/2016: Sequenom Provides Update On MaterniT Genome Test 45
Other Significant Developments 46
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 46
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Sequenom Inc, Medical Equipment, Key Facts 2
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 13
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 14
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 15
Sequenom Enters Into Licensing Agreement With LifeCodexx 16
Sequenom enters into an Agreement with University of California 17
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 18
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 19
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 20
New England Biolabs Enters Into Licensing Agreement With Sequenom 21
Sequenom Completes Public Offering Of Common Stock For US$62 Million 22
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 24
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 26
LabCorp Acquires Sequenom 27
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 29
Sequenom Inc, Key Competitors 30
Sequenom Inc, Key Employees 31
Sequenom Inc, Other Locations 32
Sequenom Inc, Subsidiaries 32

★海外企業調査レポート[Sequenom Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Quotient Sciences Ltd (Quotient Sciences), formerly Pharmaceutical Profiles Group Ltd is a drug development service provider. The company offers services such as formulation development, clinical trial manufacturing, clinical pharmacology, and commercial manufacturing services. Its formulati …
  • High Peak Royalties Ltd (HPR):電力:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Mediaset S.p.A.:企業の戦略・SWOT・財務分析
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Electrabel SA:企業の戦略的SWOT分析
    Electrabel SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • CooperVision Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Metorex Ltd:企業の戦略・SWOT・財務情報
    Metorex Ltd - Strategy, SWOT and Corporate Finance Report Summary Metorex Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Borregaard ASA (BRG):企業の財務・戦略的SWOT分析
    Borregaard ASA (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Troy Resources Limited:企業の戦略・SWOT・財務情報
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sojitz Corporation (2768):企業の財務・戦略的SWOT分析
    Sojitz Corporation (2768) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Saudi Electricity Co (5110):電力:M&Aディール及び事業提携情報
    Summary Saudi Electricity Co (SEC) is an energy utility. Through its subsidiaries, the company generates, transmits and distributes electricity; and carries out operations of the fiber optic networks, trading, realization of renewable energy, and other. It produces electricity in gas, combined, stea …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • Gibson Energy Inc (GEI)-石油・ガス分野:企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology …
  • Wacker Neuson Se:企業の戦略・SWOT・財務分析
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Polyganics BV:製品パイプライン分析
    Summary Polyganics BV (Polyganics) is a medical technology company, which develops, manufactures and commercializes bioresorbable medical devices that facilitate tissue repair and regeneration. Polyganics offers a range of products for ear, nose and throat (ENT) procedures; peripheral nerve repair ( …
  • Cooper Energy Ltd (COE):企業の財務・戦略的SWOT分析
    Summary Cooper Energy Ltd (CEL) is an oil and gas exploration and production company that offers oil production programs. The company produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, Otw …
  • Zen Technologies Limited:企業の戦略・SWOT・財務分析
    Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Zen Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報
    Summary The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in tra …
  • Western Gas Equity Partners LP:企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆